Psychedelic Medicine at the End of Life

FOREWORD BY RICK DOBLIN, Ph.D.

PROLOGUE

PART ONE

THE CASE FOR PSYCHEDELICS
AT THE END OF LIFE

CHAPTER 1
Ego Death

CHAPTER 2
From Taboo to Trials: Pioneers of the Psychedelic
Renaissance

CHAPTER 3
Studies of Psychedelics for End-of-Life Distress:
Proof of Safety and Efficacy

CHAPTER 4
Mechanism of Action: How Psychedelics Help the Dying
Overcome End-of-Life Distress

CHAPTER 5
Understanding and Treating End-of-Life Distress

PART TWO

THE STEPS TO DYING GRACEFULLY

STEP 1
Confronting Death

STEP 2
Discerning Candidacy for
Psychedelic-Assisted Psychotherapy

STEP 3
Navigating the Legal Landscape

STEP 4
Selecting the Guide, Dose, and Therapy Type

STEP 5
Managing Set and Setting

STEP 6
Surrendering

STEP 7
Integrating the Insights

STEP 8
Reckoning with the Afterlife

STEP 9
Living Fully

STEP 10
Dying Gracefully

Reconnecting in an Age of Separation

EPILOGUE
The Way Forward

AFTERWORD

REFERENCES

INDEX

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Confrontando a morte e a perda de entes queridos
• Mente, corpo, espírito: pensamento e prática
• Enfermagem dos cuidados terminais
• Medicina paliativa

PSYCHEDELIC HEALING;END-OF-LIFE CARE;DYING WITHOUT FEAR;LSD;MDMA;PSILOCYBIN;AYAHUASCA;DMT;PSYCHEDELIC THERAPY;EGO DEATH;JOHNS HOPKINS;UCLA;NYU SCHOOL OF MEDICINE;ROLAND GRIFFITHS;KATHERINE MACLEAN;IRA BYOCK;MICHAEL VERBORA;RICK DOBLIN;STANISLAV GROF;JULIE HOLLAND;TERENCE MCKENNA;DENNIS MCKENNA;PSYCHEDELIC RESEARCH;PALLIATIVE CARE